Shalby Limited reported Q1 FY27 consolidated revenue of ₹338.6 Cr, up 11.6% YoY, with PAT rising 36% to ₹10.5 Cr.

Consolidated EBITDA stood at ₹49 Cr, yielding a 14.5% margin.

The hospital segment revenue grew 7% to ₹259 Cr, with the Gurgaon unit achieving EBITDA break-even for the first time.

Management anticipates hospital EBITDA margins to improve to over 20% due to new initiatives.

MedTech revenue surged 53% YoY to ₹47 Cr, with India operations up 98%. MedTech posted its fourth consecutive positive consolidated EBITDA of ₹0.17 Cr, targeting double-digit margins from ongoing initiatives.

Management is confident in continued growth and ROCE improvement.